- Stocks
- Healthcare
- NASDAQ: AMED

Price (delayed)

$298.10

Market cap

$9.78B

P/E Ratio

58.34

Dividend/share

N/A

EPS

$5.11

Enterprise value

$10.07B

The net income has increased by 31% YoY and by 30% QoQ

AMED's EPS is up by 29% YoY and by 29% from the previous quarter

The company's debt rose by 25% YoY but it fell by 18% QoQ

The P/E is 38% above the 5-year quarterly average of 42.4 and 26% above the last 4 quarters average of 46.3

The quick ratio has decreased by 13% QoQ and by 4.5% YoY

What are the main financial stats of AMED

Market
Valuations
Earnings

Shares outstanding

32.81M

Market cap

$9.78B

Enterprise value

$10.07B

Price to earnings (P/E)

58.34

Price to book (P/B)

12.8

Price to sales (P/S)

4.82

EV/EBIT

50.75

EV/EBITDA

38.38

EV/Sales

4.98

Revenue

$2.02B

EBIT

$198.42M

EBITDA

$262.4M

Free cash flow

$293.8M

Per share
Balance sheet
Liquidity

EPS

$5.11

Free cash flow per share

$9

Book value per share

$23.29

Revenue per share

$61.89

TBVPS

$17.97

Total assets

$1.6B

Total liabilities

$844.98M

Debt

$404.27M

Equity

$756.21M

Working capital

-$26.25M

Debt to equity

0.53

Current ratio

0.94

Quick ratio

0.84

Net debt/EBITDA

1.1

Margins
Efficiency
Dividend

EBITDA margin

13%

Gross margin

41.9%

Net margin

8.2%

Operating margin

9.8%

Return on assets

11.2%

Return on equity

23.8%

Return on invested capital

39.5%

Return on capital employed

17%

Return on sales

9.8%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Amedisys stock price performed over time

Intraday

1.43%

1 week

0.77%

1 month

2.86%

1 year

65.33%

YTD

1.63%

QTD

1.63%

How have Amedisys's revenue and profit performed over time

Revenue

$2.02B

Gross profit

$847.26M

Operating income

$198.67M

Net income

$166.11M

Gross margin

41.9%

Net margin

8.2%

The net income has increased by 31% YoY and by 30% QoQ

The company's net margin rose by 26% QoQ and by 22% YoY

AMED's operating income is up by 15% year-on-year and by 9% since the previous quarter

AMED's gross profit is up by 10% year-on-year and by 5% since the previous quarter

What is Amedisys's growth rate over time

What is Amedisys stock price valuation

P/E

58.34

P/B

12.8

P/S

4.82

EV/EBIT

50.75

EV/EBITDA

38.38

EV/Sales

4.98

The P/E is 38% above the 5-year quarterly average of 42.4 and 26% above the last 4 quarters average of 46.3

AMED's EPS is up by 29% YoY and by 29% from the previous quarter

The P/B is 113% more than the 5-year quarterly average of 6.0 and 41% more than the last 4 quarters average of 9.1

AMED's equity is up by 25% year-on-year and by 4.9% since the previous quarter

The P/S is 154% more than the 5-year quarterly average of 1.9 and 51% more than the last 4 quarters average of 3.2

Amedisys's revenue has increased by 7% YoY and by 2.5% from the previous quarter

How efficient is Amedisys business performance

The ROE has grown by 23% from the previous quarter

The ROA is up by 22% since the previous quarter but it has declined by 4.3% year-on-year

The ROIC has grown by 11% from the previous quarter but it has contracted by 9% YoY

AMED's ROS is up by 7% from the previous quarter and by 3.2% YoY

What is AMED's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for AMED.

How did Amedisys financials performed over time

AMED's total assets is 90% higher than its total liabilities

The company's total liabilities rose by 39% YoY but it fell by 8% QoQ

AMED's total assets is up by 32% YoY but it is down by 2.6% QoQ

The company's debt is 47% lower than its equity

AMED's equity is up by 25% year-on-year and by 4.9% since the previous quarter

The company's debt rose by 25% YoY but it fell by 18% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.